150 related articles for article (PubMed ID: 31378108)
1. Ten-year Medicare budget impact of increased coverage for anti-obesity intervention.
Chen F; Su W; Ramasamy A; Zvenyach T; Kahan S; Kyle T; Ganguly R
J Med Econ; 2019 Oct; 22(10):1096-1104. PubMed ID: 31378108
[No Abstract] [Full Text] [Related]
2. Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US.
Hager K; Cudhea FP; Wong JB; Berkowitz SA; Downer S; Lauren BN; Mozaffarian D
JAMA Netw Open; 2022 Oct; 5(10):e2236898. PubMed ID: 36251292
[TBL] [Abstract][Full Text] [Related]
3. The estimated costs and savings of medical nutrition therapy: the Medicare population.
Sheils JF; Rubin R; Stapleton DC
J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
[TBL] [Abstract][Full Text] [Related]
4. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
[TBL] [Abstract][Full Text] [Related]
5. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
Anderson JM
J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
[TBL] [Abstract][Full Text] [Related]
6. Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
Moreno GA; Mulligan K; Huber C; Linthicum MT; Dreyfus D; Juday T; Marx SE; Gonzalez YS; Brookmeyer R; Lakdawalla DN
Am J Manag Care; 2016 May; 22(6 Spec No.):SP236-44. PubMed ID: 27266954
[TBL] [Abstract][Full Text] [Related]
7. The Financial Effect of Medicare Coverage Design and Safety Net Options for Cancer Care.
Bethay SS; Travis MJ; Batt SK; Bochenek SH; Schwieterman PA
J Manag Care Spec Pharm; 2020 Jan; 26(1):76-80. PubMed ID: 31880225
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.
Rosen AB; Hamel MB; Weinstein MC; Cutler DM; Fendrick AM; Vijan S
Ann Intern Med; 2005 Jul; 143(2):89-99. PubMed ID: 16027450
[TBL] [Abstract][Full Text] [Related]
9. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
[TBL] [Abstract][Full Text] [Related]
10. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
11. Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans.
Li Y; Heer AK; Sloane HS; Edelstein DL; Tie J; Gibbs P; Barzi A
JAMA Health Forum; 2024 May; 5(5):e241270. PubMed ID: 38819797
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer.
Ito K; Elkin E; Blinder V; Keating N; Choudhry N
Cancer; 2013 Jul; 119(13):2494-502. PubMed ID: 23775433
[TBL] [Abstract][Full Text] [Related]
13. Savings needed to fund health insurance and health care expenses in retirement: findings from a simulation model.
Fronstin P; Salisbury D; VanDerhei J
EBRI Issue Brief; 2008 May; (317):1-2, 4-27. PubMed ID: 18630312
[TBL] [Abstract][Full Text] [Related]
14. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.
King AB; Saag KG; Burge RT; Pisu M; Goel N
Osteoporos Int; 2005 Dec; 16(12):1545-57. PubMed ID: 15942702
[TBL] [Abstract][Full Text] [Related]
15. Medicare essential: an option to promote better care and curb spending growth.
Davis K; Schoen C; Guterman S
Health Aff (Millwood); 2013 May; 32(5):900-9. PubMed ID: 23650323
[TBL] [Abstract][Full Text] [Related]
16. Medicare's intensive behavioral therapy for obesity: an exploratory cost-effectiveness analysis.
Hoerger TJ; Crouse WL; Zhuo X; Gregg EW; Albright AL; Zhang P
Am J Prev Med; 2015 Apr; 48(4):419-25. PubMed ID: 25703178
[TBL] [Abstract][Full Text] [Related]
17. Illustrating potential efficiency gains from using cost-effectiveness evidence to reallocate Medicare expenditures.
Chambers JD; Lord J; Cohen JT; Neumann PJ; Buxton MJ
Value Health; 2013 Jun; 16(4):629-38. PubMed ID: 23796298
[TBL] [Abstract][Full Text] [Related]
18. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
19. Integrated care organizations: Medicare financing for care at home.
Davis K; Willink A; Schoen C
Am J Manag Care; 2016 Nov; 22(11):764-768. PubMed ID: 27870546
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]